Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients
暂无分享,去创建一个
F. Guillemin | A. Saraux | J. Berthelot | B. Combe | O. Meyer | B. Fautrel | D. Wendling | R. Flipo | X. le Loët | J. Maillefert | F. Lioté | M. de Bandt
[1] M. Weisman,et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010 , 2011, Annals of the rheumatic diseases.
[2] F. Guillemin,et al. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences. , 2009, Arthritis and rheumatism.
[3] T. Pincus,et al. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. , 2008, Arthritis and rheumatism.
[4] D. Furst,et al. Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel. , 2007, Rheumatology.
[5] M. Weisman,et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 , 2007, Annals of the rheumatic diseases.
[6] T. Pincus,et al. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). , 2007, Best practice & research. Clinical rheumatology.
[7] J. Smolen,et al. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? , 2007, Arthritis research & therapy.
[8] J. Jacobs,et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) , 2007, Annals of the rheumatic diseases.
[9] C. Bombardier,et al. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. , 2007, The Journal of rheumatology.
[10] H. Paulus,et al. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. , 2007, Arthritis and rheumatism.
[11] B Combe,et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.
[12] F. Guillemin,et al. Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy. , 2007, Joint, bone, spine : revue du rhumatisme.
[13] P. Tugwell,et al. Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity. , 2006, Clinical and experimental rheumatology.
[14] A Kavanaugh,et al. Complexities in defining remission in rheumatic diseases. , 2006, Clinical and experimental rheumatology.
[15] J. Smolen,et al. Remission of rheumatoid arthritis: should we care about definitions? , 2006, Clinical and experimental rheumatology.
[16] F Guillemin,et al. Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology , 2005, Annals of the rheumatic diseases.
[17] Philippe Ravaud,et al. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues. , 2005, The Journal of rheumatology.
[18] David T Felson,et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. , 2005, The Journal of rheumatology.
[19] H. Mäkinen,et al. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? , 2005, Annals of the rheumatic diseases.
[20] P. V. van Riel,et al. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial , 2005, Annals of the rheumatic diseases.
[21] P. V. van Riel,et al. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. , 2004, Rheumatology.
[22] A. McMahon,et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial , 2004, The Lancet.
[23] van der Heijde Dm,et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. , 1993 .
[24] M. A. van 't Hof,et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. , 1993, The Journal of rheumatology.
[25] D. Mitchell,et al. Preliminary criteria for clinical remission in rheumatoid arthritis. , 1981, Arthritis and rheumatism.
[26] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.